Acute graft pyelonephritis following renal transplantation

Transplant Infectious Disease

Volumn 8, Issue 3, 2006, Pages 140-147

  Kamath, N S ^a   John, G T ^a   Neelakantan, N ^a   Kirubakaran, M G ^a   Jacob, C K ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Acute rejection; CMV disease; Graft pyelonephritis; Mycophenolate mofetil; Renal transplant

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; DEXAMETHASONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT PYELONEPHRITIS; ACUTE GRAFT REJECTION; ACUTE PYELONEPHRITIS; ADULT; AGE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENDER; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY MALFORMATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URETER STENT; URINARY TRACT INFECTION;

ACUTE DISEASE; ADULT; CYTOMEGALOVIRUS; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PYELONEPHRITIS; RETROSPECTIVE STUDIES;

EID: 33746881717     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00148.x     Document Type: Article

References (24)

1. MASSY ZA, GUIJARRO C, WIEDERKEHR MR, MA JZ, KASISKE BL. Chronic renal allograft rejection: immunologic and non-immunologic risk factors. Kidney Int 1996: 49: 518-524.
2. MYEROWITZ RL, MEDEIROS AAM, O'BRIEN TF. Bacterial infection in renal homotransplant recipients: a study of cfty-three bacteremic episodes. Am J Med 1972: 53: 308-314.
3. TOLKOFF-RUBIN NE, RUBIN RH. Urinary tract infection in the immunocompromised host. Infect Dis Clin North Am 1997: 11: 707-717.
4. DUMMER JS, HARDY A, POORSATTAR A, HO M. Early infections in kidney, heart, and liver transplant recipients on cyclosorin. Transplantation 1983: 36: 259-267.
5. STUBY U, KAISER P, GRAFINGER P, BIESENBACH G, ZAZGORNIK J. Urinary tract infection after renal transplantation under conventional therapy and cyclosporine. Transplant Proc 1989: 21: 2110-2111.
6. GIRAL M, PASCUARIELLO G, KARAM G, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int 2002: 61: 1880-1886.
7. BASSIRI A, AMIRANSARI B, YAZDANI M, SESAVAR Y, GOL S. Renal transplantation using stents. Transplant Proc 1995: 27: 2593-2594.
8. BRANITZ BH, VEITH FJ, FREED SJ, TELLIS V, GLIEDMAN ML. Effects of ureteral stent on urinary tract infections in renal transplantation. Urology 1975: 6: 687-928.
9. BENOIT G, BLANCHET P, ESCHWEGE P, ALEXANDRE L, BENSADOUN H, CHARPENTIER B. Insertion of a double pigtail ureteral stent for the prevention of urological complications in renal transplantation: a prospective randomized study. J Urol 1996: 156: 881-884.
10. KUMAR A, VERMA BS, SRIVASTAVA A, BHANDARI M, GUPTA A, SHARMA R. Evaluation of the urological complications of living related renal transplantation at a single center during the last 10 years: impact of the Double-J® stent. J Urol 2000: 164: 657-660.
11. RIEDL CR, PLAS E, HüBNER E, et al. Bacterial colonization of ureteral stents. Eur Urol 1999: 36: 53-59.
12. TAKAI K, TOLLEMAR J, WILCZEK HE, et al. Urinary tract infections following renal transplantation. Clin Transplant 1998: 12: 19-23.
13. BYRD LH, TAPIA L, CHEIGH JS, ARONIAN J, STENZEL KH, RUBIN AL. Association between Streptococcus faecalis urinary infections and graft rejection in kidney transplantation. Lancet 1978: 2: 1167-1169.
14. RUBIN RH, COTRAN RS, TOLKOFF-RUBIN NE. Urinary tract infection pyelonephritis, and reflux nephropathy. In: BRENNER BM ed. Brenner & Rector's The Kidney (5th edn). Philadelphia: WB Saunders, 1997: 1597-1654.
15. DOCKE WD, PROSCH S, FIETZ E, et al. Cytomegalovirus reactivation and tumor necrosis factor. Lancet 1994: 343: 268-269.
16. RAO M, FINNY GJ, ABRAHAM P, et al. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers. Nephron 2000: 84: 367-373.
17. GANSCHOW R, LYONS M, KEMPER MJ, BURDELSKI M. B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient. Pediatr Transplant 2001: 5: 60-63.
18. KEVEN K, SAHIN M, KUTLAY S, et al. Immunoglobulin decciency in kidney allograft recipients. Comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis 2003: 5: 181-186.
19. STASKEWITZ A, KIRSTE G, TONSHOFF B, et al. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group. Transplantation 2001: 71: 638-644.
20. OJOGHO O, SAHNEY S, CUTLER D, et al. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab. Pediatr Transplant 2005: 9: 80-83.
21. CHEN Y, CHU SH, WEI TY, et al. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen? Transplant Proc 2004: 36: 2122-2123.
22. ALLISON AC, KOWALSKI WJ, MULLER CJ, WATERS RV, EGUI EM. Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 1993: 25: 67-70.
23. RINALDO CR Jr. Immune suppression by herpesviruses. Annu Rev Med 1990: 41: 331-338.
24. BENNEKOV T, SPECTOR D, LANGHOFF E. Induction of immunity against human cytomegalovirus. Mt Sinai J Med 2004: 71: 86-93.